Kanagawa, Japan

Hikaru Seki

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Kanagawa, JP (2015)
  • Yokohama, JP (2015)
  • Saitama, JP (2021 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Hikaru Seki: Innovator in Glycyrrhizin Biosynthesis**

Introduction

Hikaru Seki, an esteemed inventor based in Kanagawa, Japan, has made significant contributions to the field of biochemistry through his innovative work on glucuronosyltransferases. With a total of four patents to his name, Seki is recognized for his efforts in enhancing the biosynthetic processes of essential compounds.

Latest Patents

Among Hikaru Seki's latest innovations is the patent titled "Glucuronosyltransferase, gene encoding same and use thereof." This invention provides a unique enzyme that is integral to a glycyrrhizin biosynthetic system. The enzyme enables a stable and continuous production of glycyrrhizin, a compound known for its medicinal properties. Additionally, he identifies glucuronosyltransferase capable of transferring glucuronic acid to specific hydroxy groups, further contributing to the functional understanding of oleanane-type triterpenoid monoglucuronides. Through his work, Seki enhances the potential for large-scale glycyrrhizin production, showcasing the practicality and relevance of his research in contemporary applications.

Career Highlights

Hikaru Seki's career has been marked by a focus on biochemistry and enzymology. As a prominent researcher at RIKEN Corporation, he has participated in cutting-edge research aimed at understanding and applying enzymatic processes for industrial and pharmaceutical uses. His systematic approach and innovative thinking have positioned him as a key figure in the field.

Collaborations

Seki has worked closely with distinguished colleagues, including Toshiya Muranaka and Kiyoshi Ohyama. Their collaborations have yielded significant advancements in the understanding of glucuronosyltransferases and their applications. Together, they form a dynamic team that continues to push the boundaries of biotechnological innovations.

Conclusion

Hikaru Seki stands out as a leading inventor in the domain of enzymatic research, particularly with his focus on glucuronosyltransferases and glycyrrhizin. His contributions not only enhance our understanding of biochemical synthesis but also pave the way for new applications in medicine and industry. As he continues his innovative journey, the impact of his work will resonate within scientific communities and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…